$LBSR
LIBERTY STAR URANIUM & METALS CORP. Stock $lbsr

$lbsr Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224023883 Filed on June 14, 2024

Income Statement

Concept	2024 Q2
Revenue
YoY Change
Cost Of Revenue	$57.88K
YoY Change	26.07%
Gross Profit	-$57.88K
YoY Change	26.07%
Gross Profit Margin
Selling, General & Admin	$136.3K
YoY Change	64.79%
% of Gross Profit
Research & Development	$324.9K
YoY Change	5253.05%
% of Gross Profit
Depreciation & Amortization	$1.617K
YoY Change	10.91%
% of Gross Profit
Operating Expenses	$519.1K
YoY Change	285.44%
Operating Profit	-$519.1K
YoY Change	285.44%
Interest Expense	$21.53K
YoY Change	-54.19%
% of Operating Profit
Other Income/Expense, Net	$830.5K
YoY Change	5059.46%
Pretax Income	$311.4K
YoY Change	-362.59%
Income Tax
% Of Pretax Income
Net Earnings	$311.4K
YoY Change	-362.59%
Net Earnings / Revenue
Basic Earnings Per Share	$0.01
Diluted Earnings Per Share	$0.00
COMMON SHARES
Basic Shares Outstanding	49.88M shares
Diluted Shares Outstanding	62.65M shares

Balance Sheet

Concept	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.39K
YoY Change	86.42%
Cash & Equivalents	$11.39K
Short-Term Investments
Other Short-Term Assets	$38.28K
YoY Change	21.18%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$49.67K
YoY Change	31.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.03K
YoY Change	-21.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$16.03K
YoY Change	-21.55%
TOTAL ASSETS
Total Short-Term Assets	$49.67K
Total Long-Term Assets	$16.03K
Total Assets	$65.69K
YoY Change	13.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$178.2K
YoY Change	-15.75%
Accrued Expenses	$2.140K
YoY Change	-96.77%
Deferred Revenue
YoY Change
Short-Term Debt	$813.5K
YoY Change	324.95%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.690M
YoY Change	367.89%
LONG-TERM LIABILITIES
Long-Term Debt	$32.40K
YoY Change	6.23%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$32.40K
YoY Change	6.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.690M
Total Long-Term Liabilities	$32.40K
Total Liabilities	$2.723M
YoY Change	349.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$61.17M
YoY Change	6.35%
Common Stock	$58.62M
YoY Change	2.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.657M
YoY Change
Total Liabilities & Shareholders Equity	$65.69K
YoY Change	13.0%

Cashflow Statement

Concept	2024 Q2
OPERATING ACTIVITIES
Net Income	$311.4K
YoY Change	-362.59%
Depreciation, Depletion And Amortization	$1.617K
YoY Change	10.91%
Cash From Operating Activities	-$435.7K
YoY Change	263.36%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$375.0K
YoY Change	301.47%
NET CHANGE
Cash From Operating Activities	-$435.7K
Cash From Investing Activities
Cash From Financing Activities	$375.0K
Net Change In Cash	-$60.71K
YoY Change	129.05%
FREE CASH FLOW
Cash From Operating Activities	-$435.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q2	LBSR	Increase Decrease In Accrued Expenses To Related Party IncreaseDecreaseInAccruedExpensesToRelatedParty		usd
CY2023Q2	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023Q2	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2024Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2024Q2	LBSR	Proceeds From Receipt Of Subscription Receivable ProceedsFromReceiptOfSubscriptionReceivable		usd
CY2024Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q2	LBSR	Resolution Of Derivative Liabilities Due To Debt Conversions And Untainted Warrants ResolutionOfDerivativeLiabilitiesDueToDebtConversionsAndUntaintedWarrants		usd
CY2024Q2	LBSR	Debt Discounts Due To Derivative Liabilities DebtDiscountsDueToDerivativeLiabilities		usd
CY2024Q2	us-gaap	Stock Issued1 StockIssued1		usd
CY2024Q2	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1		usd
CY2024Q2	LBSR	Cashless Exercise Of Warrants CashlessExerciseOfWarrants		usd
CY2023Q2	LBSR	Settlement Of Subscription And Interest Receivable SettlementOfSubscriptionAndInterestReceivable		usd
CY2024Q2	LBSR	Derivative Gain Net DerivativeGainNet		usd
CY2023Q2	LBSR	Derivative Gain Net DerivativeGainNet		usd
CY2024Q2	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
CY2023Q2	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements		usd
CY2024Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Purchases FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchases		usd
CY2024Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2024Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2024Q2	us-gaap	Exploration Expense ExplorationExpense	324929	usd
CY2023Q2	us-gaap	Exploration Expense ExplorationExpense	6065	usd
CY2024Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	57881	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	45914	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	31712	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	40963	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	104564	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41733	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	519086	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	134675	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-519086	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-134675	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	21534	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	47006	usd
CY2024Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	969	usd
CY2024Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	851032	usd
CY2023Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	63102	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	830467	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	16096	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	311381	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-118579	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49867529	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19240464	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62645347	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19240464	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-3062799	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	77626	usd
CY2024Q2	LBSR	Stock Issued During Period Value Settlement Of Subscription Receivable StockIssuedDuringPeriodValueSettlementOfSubscriptionReceivable	16750	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	311381	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-579286	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-579286	usd
CY2023Q2	LBSR	Stock Issued During Period Value Receipt Of Subscription Receivable StockIssuedDuringPeriodValueReceiptOfSubscriptionReceivable	16368	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	70943	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	19265	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	43931	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-118579	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-118579	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-547358	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-547358	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	311381	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-118579	usd
CY2024Q2	us-gaap	Depreciation Depreciation	1617	usd
CY2023Q2	us-gaap	Depreciation Depreciation	1458	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	77626	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	19265	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	9176	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	45248	usd
CY2024Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	851032	usd
CY2023Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	63102	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-347	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	204	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	13029	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3999	usd
CY2024Q2	LBSR	Increase Decrease In Accrued Expenses To Related Party IncreaseDecreaseInAccruedExpensesToRelatedParty	2143	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-435713	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-119913	usd
CY2024Q2	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	10000	usd
CY2024Q2	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	285000	usd
CY2023Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2962	usd
CY2024Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	100000	usd
CY2023Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	80000	usd
CY2023Q2	LBSR	Proceeds From Receipt Of Subscription Receivable ProceedsFromReceiptOfSubscriptionReceivable	16368	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	375000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	93406	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-60713	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26507	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	72099	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32616	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11386	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6109	usd
CY2024Q2	us-gaap	Interest Paid Net InterestPaidNet	474	usd
CY2023Q2	LBSR	Resolution Of Derivative Liabilities Due To Debt Conversions And Untainted Warrants ResolutionOfDerivativeLiabilitiesDueToDebtConversionsAndUntaintedWarrants	43931	usd
CY2023Q2	LBSR	Debt Discounts Due To Derivative Liabilities DebtDiscountsDueToDerivativeLiabilities	33720	usd
CY2023Q2	us-gaap	Stock Issued1 StockIssued1	70943	usd
CY2023Q2	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	1579	usd
CY2024Q2	LBSR	Prepaid Insurance Financed With Note Payable PrepaidInsuranceFinancedWithNotePayable	24750	usd
CY2023Q2	LBSR	Prepaid Insurance Financed With Note Payable PrepaidInsuranceFinancedWithNotePayable	24850	usd
CY2023Q2	LBSR	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	16750	usd
CY2024Q2	LBSR	Settlement Of Subscription And Interest Receivable SettlementOfSubscriptionAndInterestReceivable	17230	usd
CY2024Q2	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_80E_eus-gaap--BasisOfAccounting_zJ95WKxdFc1h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82B_zdhdInFF8OEj">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements included herein have been prepared by Liberty Star Uranium & Metals Corp. (the “Company”, “we”, “our”) without audit, pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and should be read in conjunction with our annual report on Form 10-K for the year ended January 31, 2024 as filed with the SEC on May 15, 2024. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been omitted, as permitted by the SEC, although we believe the disclosures which are made are adequate to make the information presented not misleading. The consolidated financial statements reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position at April 30, 2024, and the results of our operations and cash flows for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim results are subject to significant seasonal variations and the results of operations for the three months ended April 30, 2024, are not necessarily indicative of the results to be expected for the full year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1696426	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2547458	usd
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1809207	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	10968612	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	311381	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-118579	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49867529	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19240464	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	311381	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-118579	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	311381	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-118579	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49867529	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19240464	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	10968612	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1809207	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62645347	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19240464	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024Q1	LBSR	Stock Options Exercised StockOptionsExercised	75000	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	70002	shares
CY2024Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	101100	usd
CY2024Q1	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	117850	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2808760	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.83
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	30000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.05
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	75000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.05
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2763760	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.85
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2287508	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.96
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y6M18D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	549484	usd
CY2024Q2	us-gaap	Share Price SharePrice	0.325
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	150480	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	14187933	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	13680401	shares
CY2024Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y2M23D
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.13
CY2024Q2	LBSR	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingIntrinsicValue	3394192	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10888894	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10888894	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49883863	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49883863	shares
CY2024Q2	LBSR	Common Stock Shares Growth Monthly Percentage CommonStockSharesGrowthMonthlyPercentage	0.0304	pure
CY2024Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	500000	usd
CY2024Q2	LBSR	Common Stock Discount Percentage CommonStockDiscountPercentage	0.25	pure
CY2024Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	851032	usd
CY2023Q2	LBSR	Reclassifications Due To Conversion Of Convertible Notes ReclassificationsDueToConversionOfConvertibleNotes	43931	usd
CY2023Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	63102	usd
CY2024Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	2547458	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	172393	usd
CY2024Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	851032	usd
CY2023Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	63102	usd
CY2023Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements	-43931	usd
CY2023Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Purchases FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchases	33720	usd
CY2024Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	1696426	usd
CY2023Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	99080	usd
CY2024Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	851032	usd
CY2023Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	63102	usd
CY2024Q2	us-gaap	Convertible Debt ConvertibleDebt	236000	usd
CY2024Q1	us-gaap	Convertible Debt ConvertibleDebt	110000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	31824	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	15000	usd
CY2024Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	204176	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	95000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	0	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	33720	usd
CY2024Q2	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	26000	usd
CY2023Q2	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	17350	usd
CY2024Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9176	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	45248	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	24750	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	32400	usd
CY2023Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	24750	usd
CY2023Q2	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	2729	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	32400	usd
CY2024Q2	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	2729	usd
CY2024Q2	us-gaap	Payments For Rent PaymentsForRent	165	usd
CY2024Q2	LBSR	Lease Due Date LeaseDueDate	2023-09-01

Files In Submission

Name	View Source	Status
0001493152-24-023883-index-headers.html	Edgar Link	pending
0001493152-24-023883-index.html	Edgar Link	pending
0001493152-24-023883.txt	Edgar Link	pending
0001493152-24-023883-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
lbsr-20240430.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
lbsr-20240430_cal.xml	Edgar Link	unprocessable
lbsr-20240430_def.xml	Edgar Link	unprocessable
lbsr-20240430_lab.xml	Edgar Link	unprocessable
lbsr-20240430_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LBSR
LIBERTY STAR URANIUM & METALS CORP. Stock $lbsr

2024 Q2 Form 10-Q Financial Statement

#000149315224023883 Filed on June 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LBSR LIBERTY STAR URANIUM & METALS CORP. Stock $lbsr

2024 Q2 Form 10-Q Financial Statement

#000149315224023883 Filed on June 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LBSR
LIBERTY STAR URANIUM & METALS CORP. Stock $lbsr